照护现场诊断市场－预测至2025-2030年

预计照护现场将从 2025 年的 367.25 亿美元成长至 2030 年的 492.09 亿美元，复合年增长率为 6.03%。

照护现场(POC) 市场涵盖在传统实验室之外的床边进行的检测，由于技术进步和医疗保健需求的不断增长，该市场正在显着增长。 POC 检测能够快速评估、诊断、预后和筛检，减少错误并提高效率。可携式、手持式和可移动式设备的普及，将检测能力从医院扩展到家庭、紧急护理和便利诊所，满足了日益增长的便捷诊断需求。

市场驱动因素

慢性病和感染疾病率上升是照护现场诊断市场的主要驱动力。中国和印度等新兴国家心血管疾病和糖尿病盛行率的上升正在推动需求。例如，国际糖尿病联盟报告称，2021 年全球 5.37 亿 20-79 岁成年人患有糖尿病，其中相当一部分国家正在经历糖尿病。同样，爱滋病毒和结核病等感染疾病也在刺激市场成长。联合国爱滋病规划署估计，2019 年有 2,060 万人感染爱滋病毒，其中包括印度的 210 万人，这推动了对照护现场诊断的需求，以加速治疗。世界卫生组织 (WHO) 指出，印度的结核病病例负担很高，2020 年达到 264 万例，进一步凸显了在资源有限的环境中快速诊断的必要性。此外，呼吸道融合细胞病毒(RSV) 每年影响全球 400 万至 500 万名儿童，因此需要进行 POC 检测以有效管理此类疾病。

地理视角

预计北美地区在预测期内将见证照护现场市场显着成长。新冠病例激增是推动快速检测解决方案需求的主要驱动因素。该地区受益于强劲的产品创新、感染疾病和慢性病的流行以及政府鼓励早期发现和定期体检的支持政策。美国和加拿大是关键市场，其驱动力包括医疗保健支出的增加、医院和诊断实验室数量的增加以及产业参与者之间的策略联盟。这些因素共同推动了即时诊断设备的普及，使北美地区成为市场扩张的领导者。

由于慢性病和感染疾病的日益普及（尤其是在北美地区）、可携式设备的技术进步以及医疗政策的扶持，照护现场诊断市场正在迅速扩张。已开发市场和新兴市场对在各种环境下快速便捷诊断的需求，以及应对关键医疗挑战的需求，进一步推动了市场的发展。

本报告的主要优点

• 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
• 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
• 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
• 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
• 适用范围广：对于新兴企业、科学研究机构、顾问公司、中小企业、大型企业都有利且划算。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

• 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
• 成长机会、挑战、供应链前景、法律规范与趋势分析
• 竞争定位、策略和市场占有率分析
• 各细分市场和地区（包括国家）的收益成长和预测分析

公司简介

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 研究范围
• 市场区隔

第三章 商业景气

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策法规
• 策略建议

第四章 技术展望

第五章照护现场）

• 介绍
• 心臟代谢监测套件
• 传染病检查套件
• 血糖监测套件
• 凝血监测套件
• 肿瘤/癌症标记物
• 妊娠和生育能力测试
• 尿液检查套件
• 血液检查
• 其他的

6.照护现场诊断市场（按平台）

• 介绍
• 横向流动化验
• 量油尺
• 微流体
• 分子诊断
• 其他的

7.照护现场诊断市场（按模式）

• 介绍
• 处方笺
• 场外交易（OTC）

8.照护现场诊断市场（按最终用户）

• 介绍
• 医院
• 诊断中心
• 其他的

第九章照护现场诊断市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第十章竞争格局及分析

• 主要企业和策略分析
• 市场占有率分析
• 合併、收购、协议和合作
• 竞争仪錶板

第十一章 公司简介

• Abbott Laboratories
• Becton, Dickinson and Company
• Biosynex
• Danaher Corporation
• EKF Diagnostics
• Nova Biomedical
• Quidel Corporation
• Siemens AG
• Trinity Biotech
• WerfenLife SA

第十二章 附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要利益
• 调查方法
• 简称

The point of care diagnostic market is expected to grow from USD 36.725 billion in 2025 to USD 49.209 billion in 2030, at a CAGR of 6.03%.

The point-of-care (POC) diagnostics market, encompassing bedside testing performed outside traditional laboratory settings, has seen significant growth driven by technological advancements and rising healthcare needs. POC testing enables rapid evaluation, diagnosis, prognosis, and screening, reducing errors and improving efficiency. The availability of portable, handheld, and transportable devices has expanded testing capabilities beyond hospitals to homes, emergency care, and convenience clinics, meeting the growing demand for accessible diagnostics.

Market Drivers

The increasing prevalence of chronic and infectious diseases is a primary driver of the POC diagnostics market. In emerging nations like China and India, the rising incidence of cardiovascular diseases and diabetes has heightened demand. For instance, the International Diabetes Federation reported in 2021 that 537 million adults aged 20-79 globally were living with diabetes, with significant numbers in these countries. Similarly, infectious diseases such as HIV and tuberculosis (TB) are fueling market growth. UNAIDS estimated 20.6 million people were living with HIV in 2019, including 2.1 million in India, driving demand for POC diagnostics to accelerate treatment. The World Health Organization noted India's high TB burden, with 2.64 million cases in 2020, further emphasizing the need for rapid diagnostics in resource-limited settings. Additionally, respiratory syncytial virus (RSV) affects four to five million children annually worldwide, contributing to the demand for POC testing to manage such disorders effectively.

Geographical Outlook

North America is poised for significant growth in the POC diagnostics market during the forecast period. The surge in COVID-19 cases has been a key factor, increasing the need for rapid testing solutions. The region benefits from robust product innovation, a rising incidence of infectious and chronic diseases, and supportive governmental initiatives promoting early detection and regular health check-ups. The United States and Canada are pivotal markets, driven by increased healthcare expenditure, a growing number of hospitals and diagnostic laboratories, and strategic collaborations among industry players. These factors collectively enhance the adoption of POC devices, positioning North America as a leader in market expansion.

The POC diagnostics market is expanding rapidly due to the rising prevalence of chronic and infectious diseases, technological advancements in portable devices, and supportive healthcare policies, particularly in North America. The market's growth is further propelled by the need for rapid, accessible diagnostics in diverse settings, addressing critical healthcare challenges in both developed and emerging regions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Point of Care Diagnostics Market Segmentation

By Testing

• Cardio-Metabolic Monitoring Kits
• Infectious Disease Testing Kits
• Glucose Monitoring Kits
• Coagulation Monitoring Kits
• Tumor/Cancer Markers
• Pregnancy & Fertility Testing
• Urinalysis Testing Kit
• Hematology Testing
• Others

By Platform

• Lateral Flow Assay
• Dipstick
• MicroFluids
• Molecular Diagnostics
• Others

By Mode

• Prescription
• Over-the-counter (OTC)

By End-User

• Hospitals
• Diagnostics Centers
• Others

By Geography

• North America
• USA
• Canada
• Others
• South America
• Brazil
• Others
• Europe
• Germany
• UK
• France
• Spain
• Others
• Middle East and Africa
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. POINT OF CARE DIAGNOSTICS MARKET BY TESTING

• 5.1. Introduction
• 5.2. Cardio-Metabolic Monitoring Kits
• 5.3. Infecious Disease Testing Kits
• 5.4. Glucose Monitoring Kits
• 5.5. Coagulation Monitoring Kits
• 5.6. Tumor/Cancer Marker
• 5.7. Pregnancy & Fertility Testing
• 5.8. Urinalysis Testing Kit
• 5.9. Hematology Testing
• 5.10. Others

6. POINT OF CARE DIAGNOSTICS MARKET BY PLATFORM

• 6.1. Introduction
• 6.2. Lateral Flow Assay
• 6.3. Dipsticks
• 6.4. Microfluids
• 6.5. Molecular Diagnostics
• 6.6. Others

7. POINT OF CARE DIAGNOSTICS MARKET BY MODE

• 7.1. Introduction
• 7.2. Prescription
• 7.3. Over-The-Counter (OTC)

8. POINT OF CARE DIAGNOSTICS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Diagnostics Centers
• 8.4. Others

9. POINT OF CARE DIAGNOSTICS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Abbott Laboratories
• 11.2. Becton, Dickinson and Company
• 11.3. Biosynex
• 11.4. Danaher Corporation
• 11.5. EKF Diagnostics
• 11.6. Nova Biomedical
• 11.7. Quidel Corporation
• 11.8. Siemens AG
• 11.9. Trinity Biotech
• 11.10. WerfenLife S.A

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations